Changing the Course of Kidney Care™
Chinook is now a Novartis Company!
On August 11, 2023, Novartis completed its acquisition of Chinook Therapeutics.
Chinook is a clinical-stage biopharmaceutical company discovering, developing and commercializing precision medicines for rare, severe chronic kidney diseases.
Details on upcoming events are not yet available.
Click here for webcast